Qiansui International Group Co Ltd
Change company Symbol lookup
Select an option...
QIAN Qiansui International Group Co Ltd
BV Brightview Holdings Inc
PFE Pfizer Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
AEG Aegon NV
MGP MGM Growth Properties LLC
WRB W R Berkley Corp
Go


Based in China
Company profile

Qiansui International Group Co Ltd, formerly Ariel Clean Energy Inc, is a shell company. The Company is engaged in seeking new business opportunities with business entities for merger with or acquisition of a target business. The Company may seek a business opportunity with entities that have commenced operations, or entities wishing to utilize the public marketplace in order to raise additional capital to expand business development activities, to develop a new product or service, or for other corporate purposes. The Company may acquire assets and establish subsidiaries in various businesses or acquire existing businesses as subsidiaries. In implementing a structure for a particular business acquisition or opportunity, the Company may become a party to a merger, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Company may also acquire stock or assets of an existing business. The Company does not have a source of revenue.

Closing Price
$1.23
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.23
Day's Low
1.23
Volume
(Heavy Day)
Volume:
550

10-day average volume:
418
550

SHAREHOLDER ALERT: PLUG DOX ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

10:32 pm ET May 3, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 3, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Plug Power Inc. (NASDAQ:PLUG)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/plug-power-inc-loss-submission-form?prid=15441&wire=1

Lead Plaintiff Deadline: May 7, 2021

Class Period: November 9, 2020 - March 1, 2021

Allegations against PLUG include that: (1) the Company would be unable to timely file its 2020 annual report due to delays related to the review of classification of certain costs and the recoverability of the right to use assets with certain leases; (2) the Company was reasonably likely to report material weaknesses in its internal control over financial reporting; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Amdocs Limited (NASDAQ:DOX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/amdocs-limited-loss-submission-form?prid=15441&wire=1

Lead Plaintiff Deadline: June 8, 2021

Class Period: December 13, 2016 - March 30, 2021

Allegations against DOX include that: (i) Amdocs overstated its profits, cash, and liquidity, while understating its debt; (ii) Amdocs concealed its large borrowing; (iii) while Amdocs' reported results showed that its North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15441&wire=1

Lead Plaintiff Deadline: June 18, 2021

Class Period: June 15, 2020 - April 4, 2021

Allegations against ACAD include that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Image: https://www.accesswire.com/users/newswire/images/644258/vw-logo.png

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.

39 East Broadway

Suite 304

New York, NY 10002

Tel. 212.425.1140

Fax. 866.699.3880

E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

View source version on accesswire.com:

https://www.accesswire.com/644258/SHAREHOLDER-ALERT-PLUG-DOX-ACAD-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.